A Comprehensive Guide To Estimated Glomerular Filtration Rate (eGFR): What Is the Normal Range?
Estimated Glomerular Filtration Rate (eGFR) is internationally recognized in medicine as the most accurate and fundamental indicator for assessing kidney function and staging Chronic Kidney Disease (CKD).
Many people feel anxious when their health check report shows a normal creatinine level but an unexpectedly low eGFR. The glomeruli are microscopic capillary filtering units within the kidneys, and eGFR indicates how many milliliters of blood these filters can clear of waste products each minute.
This article provides an in-depth breakdown of eGFR testing methods, normal reference values, the 5 stages of chronic kidney disease, causes of declining numbers, accompanying symptoms, evidence-based ways to improve and slow deterioration, and frequently asked questions.
What Is Estimated Glomerular Filtration Rate (eGFR)? How Is It Tested and Calculated?
The kidneys function like 24-hour plasma filters, containing roughly 2 million glomeruli in total. eGFR measures the combined volume (in milliliters) of blood waste that all glomeruli across both kidneys can filter out in one minute, reported in units of $\text{mL/min/1.73m}^2$.
Core Testing and Calculation Methods
An eGFR test generally does not measure eGFR as an isolated substance directly from the blood. Instead, it measures blood levels of serum creatinine or cystatin C, which are then combined with a patient's personal parameters using mathematical equations:
- Serum Creatinine-Based Calculation (Most Common): Measures creatinine (Cr), a metabolic waste product of muscle breakdown. The value is combined with the patient's age, biological sex, and demographic variables using internationally validated formulas—such as the CKD-EPI formula or the MDRD formula—to derive the estimated eGFR.
- Serum Cystatin C-Based Calculation (Higher Precision): For patients who are severely underweight, morbidly obese, have high muscle mass (e.g., bodybuilders), or have had an amputation, relying solely on creatinine can yield distorted estimates. In such cases, measuring cystatin C—a protein produced by all nucleated cells throughout the body—provides an accurate eGFR unaffected by muscle mass variations.
- 24-Hour Urine Creatinine Clearance Rate (Ccr): Involves collecting urine over a continuous 24-hour period alongside a blood draw to determine the kidneys' true operational clearance capacity over an entire day.
What Is a Normal eGFR Value? Stages 1–5 of Chronic Kidney Disease (CKD)
Under optimal conditions, the eGFR of a young, healthy adult ranges between $90\text{ and }120\text{ mL/min/1.73m}^2$.
However, eGFR declines naturally with age. Beyond age 30 to 40, eGFR typically undergoes a physiological decrease of approximately $0.8\text{ to }1.0\text{ mL/min/1.73m}^2\text{ per year}$.
Comparison Table: 5 Stages of Chronic Kidney Disease (CKD)
International clinical guidelines categorize chronic kidney disease into five stages based on eGFR values (with Stage 3 divided into 3a and 3b):
| CKD Stage | Clinical Description | eGFR Range (mL/min/1.73m2) | Kidney Status & Clinical Action |
| Stage 1 | Normal or elevated function, with kidney damage | $\ge 90$ | Glomeruli function normally; diagnosed only if accompanied by proteinuria, hematuria, or structural/ultrasound abnormalities. Routine annual monitoring recommended. |
| Stage 2 | Mild decline, with kidney damage | $60 – 89$ | Mild functional loss; diagnosed if paired with persistent kidney damage (e.g., proteinuria). Requires proactive blood pressure and blood sugar control. |
| Stage 3a | Mild-to-moderate decline | $45 – 59$ | Moderate loss of filtering ability; requires active medical intervention and nephrology follow-up to prevent progression. |
| Stage 3b | Moderate-to-severe decline | $30 – 44$ | Substantial loss of kidney capacity; dietary protein restriction recommended to reduce toxic burden. |
| Stage 4 | Severe decline | $15 – 29$ | Significant functional deficit; preparation for renal replacement options (vascular access planning, dialysis education, transplant evaluation). |
| Stage 5 | Kidney failure (End-Stage Renal Disease, ESRD) | $< 15$ | Kidneys can no longer sustain homeostasis; evaluation for dialysis or kidney transplantation. |
💡 Clinical Interpretation Tip: If an eGFR falls between $60\text{ and }89$ in the total absence of proteinuria, hematuria, or ultrasound abnormalities, it typically represents normal physiological aging rather than chronic kidney disease.
7 Major Causes of a Declining eGFR
When eGFR drops persistently below normal thresholds, it indicates ongoing chronic damage or acute kidney injury. Primary causes include:
- Diabetes Mellitus (Diabetic Nephropathy) — The Leading Cause of Dialysis
Chronic hyperglycemia leads to elevated glomerular capillary pressure (hyperfiltration), causing capillary wall thickening, glomerulosclerosis, and gradual loss of filtration capacity. - Hypertension (Hypertensive Nephrosclerosis) — The Second Leading Cause
Persistently elevated blood pressure damages renal microvasculature, resulting in glomerular sclerosis, ischemia, atrophy, and a steady reduction in filtration rate. - Glomerulonephritis
Conditions such as IgA nephropathy, membranous nephropathy, or systemic autoimmune diseases (e.g., Systemic Lupus Erythematosus / Lupus Nephritis) trigger immune-complex deposition in the glomeruli, causing progressive inflammation and scarring. - Misuse of Nephrotoxic Medications and Herbal Remedies
- Analgesics: Long-term or excessive use of nonsteroidal anti-inflammatory drugs (NSAIDs).
- Unregulated Herbal Formulations: Consuming unverified folk remedies containing toxic botanicals or aristolochic acid.
- Intravenous Radiocontrast Media: Iodinated contrast agents used during contrast-enhanced CT scans or angiographies (which can trigger contrast-induced acute kidney injury).
- Analgesics: Long-term or excessive use of nonsteroidal anti-inflammatory drugs (NSAIDs).
- Gout and Hyperuricemia
Urate microcrystals deposit in renal interstitial tissue, causing chronic interstitial nephritis, uric acid urolithiasis, and tubular obstruction. - Post-Renal Urinary Tract Obstruction
Benign prostatic hyperplasia (BPH), bilateral nephrolithiasis, or pelvic masses compressing the ureters lead to hydronephrosis, urinary backpressure, and parenchymal parenchymal damage. - Acute Pre-Renal Factors (Temporary Decline)
Severe dehydration (insufficient fluid intake, severe diarrhea, persistent vomiting), acute massive hemorrhage, or systemic sepsis sharply reduce renal perfusion, resulting in a sudden, transient drop in filtration rate.
What Symptoms Occur When eGFR Declines?
Known as "silent organs," the kidneys possess immense functional reserve:
- Early Stages (Stages 1 to 3a): Patients are frequently asymptomatic. Declines in eGFR or the onset of foamy urine (proteinuria) are most often detected incidentally during routine blood and urine screenings.
- Moderate to Advanced Stages (Stages 3b to 5): When eGFR drops below 45 or 30, the kidneys can no longer clear fluid and metabolic toxins, resulting in the classic constellation of symptoms:
- Foamy Urine (Proteinuria): Dense, microscopic bubbles in the urine that do not disperse after standing.
- Edema (Fluid Retention): Pitting edema over the ankles and shins, accompanied by periorbital puffiness upon waking.
- High Blood Pressure: Fluid overload expands intravascular volume, driving up systemic blood pressure.
- Anemia: Impaired production of erythropoietin (EPO) by diseased kidneys leads to pale skin, dizziness, and chronic fatigue.
- Exhaustion & Uremic Symptoms: Profound weakness, nausea, vomiting, loss of appetite, intractable skin pruritus, and a metallic or urine-like breath odor.
- Foamy Urine (Proteinuria): Dense, microscopic bubbles in the urine that do not disperse after standing.
How to Improve and Slow Down eGFR Decline: 6 Evidence-Based Strategies
Patients frequently ask: "Once eGFR drops, can it ever go back up?"
- Acute Kidney Injury (AKI): If the drop is triggered by dehydration, drug toxicity, or acute infection, restoring fluid volume and discontinuing offending agents often allows eGFR to rebound significantly or return to baseline.
- Chronic Kidney Disease (CKD): If nephrons have undergone sclerotic, irreversible fibrotic death from long-standing diabetes or hypertension, they cannot regenerate. The therapeutic priority shifts to slowing disease progression, preserving remaining nephrons, and delaying or avoiding dialysis.
Key evidence-based strategies include:
1. Rigorous Control of the "Three Highs" (Blood Sugar, Blood Pressure, Lipids)
- Blood Pressure Targets: Maintain blood pressure below $< 130/80\text{ mmHg}$ for most CKD patients (stricter targets may apply if significant albuminuria is present).
- Glycemic Targets: Diabetic individuals should aim for a glycated hemoglobin (HbA1c) of $< 7.0\%$.
2. Initiation of Renoprotective Pharmacotherapy
Modern pharmacological therapies can slow progression while managing blood pressure and glycemic markers:
- SGLT2 Inhibitors: Demonstrated in major clinical trials to reduce intraglomerular hypertension, slow eGFR decline rates, and reduce albuminuria.
- ACE Inhibitors / ARBs: Dilate the efferent glomerular arteriole, lowering intraglomerular pressure and decreasing urinary protein excretion.
3. Nutritional Management (Low-Sodium & Controlled Protein)
- Sodium Restriction: Limit salt intake to under 5 g daily (sodium $< 2,000\text{ mg}$) to alleviate fluid retention and control hypertension.
- Targeted Protein Moderation (CKD Stage 3b and above): Under a renal dietitian's supervision, adjust daily protein intake to $0.6\text{ to }0.8\text{ g per kg of body weight}$ to minimize urea nitrogen accumulation and reduce renal workload.
4. Adequate Hydration and Avoiding Urinary Retention
Maintain a daily intake of $1,500\text{ to }2,000\text{ mL}$ of water (unless fluid-restricted due to end-stage heart failure or advanced oliguric CKD), facilitating solute excretion while preventing urolithiasis and urinary tract infections.
5. Elimination of Nephrotoxins and Unverified Remedies
Avoid self-administering over-the-counter NSAID pain relievers, proprietary herbal pills, or unverified kidney tonics. Always inform physicians of your eGFR baseline before undergoing scans requiring iodinated contrast media.
6. Smoking Cessation and Weight Optimization
Nicotine induces renal arteriolar vasoconstriction and sclerosis. Keeping body mass index (BMI) within the healthy range of $18.5\text{ to }24$ reduces glomerular hyperfiltration stress.
Frequently Asked Questions (FAQ)
Q1: My health checkup shows an eGFR of 55. Does this mean I need dialysis?
Not at all. Dialysis is still far off. An eGFR of 55 corresponds to Stage 3a CKD (mild-to-moderate impairment). Dialysis is generally considered only in Stage 5 (eGFR $< 15$) when life-threatening uremic complications, refractory fluid overload, or electrolyte imbalances fail to respond to medical therapy. By controlling blood sugar and blood pressure, modifying your diet, and taking prescribed renoprotective medications, kidney function can often be stabilized for decades.
Q2: Why was my eGFR 75 last quarter but 68 this time? Can values fluctuate?
Yes, physiological fluctuations are completely normal. Because eGFR is calculated from serum creatinine, temporary elevations in blood creatinine—caused by mild dehydration prior to the blood draw, consuming large portions of red or cooked meat the night before, or rigorous strength training causing muscle breakdown—will yield a lower calculated eGFR. An isolated fluctuation is not cause for alarm; repeat the test in 1 to 3 months to evaluate the broader longitudinal trend.
Q3: Does exercise harm the kidneys? Can individuals with low eGFR exercise safely?
Regular, moderate exercise protects kidney health. Aerobic activities such as brisk walking, jogging, swimming, and cycling support healthy blood pressure and blood glucose regulation while enhancing vascular compliance. However, avoid extreme, exhausting overexertion (such as ultramarathons or excessive lifting that could provoke rhabdomyolysis), and stay adequately hydrated before, during, and after physical activity to prevent dehydration-induced acute renal injury.